D-574-2013 Class III Terminated
FDA drug recall D-574-2013 was initiated by Novartis Consumer Health on Feb 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 99,660 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 12, 2013
- Initiation Date
- Feb 19, 2013
- Termination Date
- Nov 26, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99,660 tubes
Product description
Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..
Distribution pattern
Nationwide and Puerto Rico, and Panama. Military distribution made.
Code information
Lot numbers and exp dates: 10108716 31-Mar-2013, 10111510 30-Apr-2013, 10113801 31-May-2013, 10113839 30-Apr-2013, 10115616 31-Aug-2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-574-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026